tiprankstipranks
Amedisys Inc (AMED)
NASDAQ:AMED
Holding AMED?
Track your performance easily

Amedisys (AMED) Technical Analysis

449 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Amedisys Inc’s (AMED) Moving Averages Convergence Divergence (MACD) indicator is -1.74, suggesting Amedisys Inc is a Buy.
Amedisys Inc’s (AMED) 20-Day exponential moving average is 92.57, while Amedisys Inc’s (AMED) share price is $90.64, making it a Sell.
Amedisys Inc’s (AMED) 50-Day exponential moving average is 94.54, while Amedisys Inc’s (AMED) share price is $90.64, making it a Sell.

Amedisys (AMED) Pivot Points

Nov 23, 2024, 07:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
89.46
89.62
89.89
90.05
90.32
90.48
90.75
Fibonacci
89.62
89.78
89.89
90.05
90.21
90.32
90.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amedisys (AMED) Moving Averages

Nov 23, 2024, 07:17 PM
Period
Simple
Exponential
MA5
90.05Buy
90.38Buy
MA10
90.48Buy
91.11Sell
MA20
93.17Sell
92.57Sell
MA50
95.34Sell
94.54Sell
MA100
96.54Sell
95.26Sell
MA200
94.79Sell
94.76Sell
Amedisys Inc’s (AMED) 10-Day exponential moving average is 91.11, while Amedisys Inc’s (AMED) share price is $90.64, making it a Sell.
Amedisys Inc’s (AMED) 100-Day exponential moving average is 95.26, while Amedisys Inc’s (AMED) share price is $90.64, making it a Sell.
Amedisys Inc’s (AMED) stock price is $90.64 and Amedisys Inc’s (AMED) 50-day simple moving average is 95.34, creating a Sell signal.
Amedisys Inc’s (AMED) stock price is $90.64 and Amedisys Inc’s (AMED) 100-day simple moving average is 96.54, creating a Sell signal.
Amedisys Inc’s (AMED) stock price is $90.64 and Amedisys Inc’s (AMED) 200-day simple moving average is 94.79, creating a Sell signal.

Amedisys (AMED) Technical Indicators

Nov 23, 2024, 07:17 PM
Name
Value
Implied Action
RSI (14)
32.95
Neutral
STOCH (9,6)
28.45
Neutral
STOCHRSI (14)
16.10
Buy
MACD (12,26)
-1.74
Buy
ADX (14)
42.57
Neutral
Williams %R
-79.79
Buy
CCI (14)
-68.82
Neutral
ATR (14)
1.15
-
Ultimate Oscillator
55.63
Neutral
ROC
-4.98
Sell
Amedisys Inc’s (AMED) Relative Strength Index (RSI) is 32.95, creating a Neutral signal.
Amedisys Inc’s (AMED) Trend Strength Indicator (ADX) is 42.57, creating a Neutral signal.
Amedisys Inc’s (AMED) Commodity Channel Index (CCI) is -68.82, creating a Neutral signal.
Amedisys Inc’s (AMED) Price Rate of Change (ROC) is -4.98, creating a Sell signal.

FAQ

Is AMED a Buy, Hold, or Sell?
Based on AMED’s technical indicators, AMED is a Sell.
    What is AMED’s RSI (14)?
    AMED’s RSI (14) is 32.95, which suggests AMED is a Neutral.
      What is AMED’s MACD?
      AMED’s MACD is -1.74, which suggests AMED is a Buy.
        What is AMED’s 5-day moving average?
        AMED’s 5-day moving average is 90.05, which suggests AMED is a Buy.
          What is AMED’s 20-day moving average?
          AMED 20-day moving average is 93.17, which suggests AMED is a Sell.
            What is AMED’s 50-day moving average?
            AMED’s 50-day moving average is 95.34, which suggests AMED is a Sell.
              What is AMED’s 200-day moving average?
              AMED’s 200-day moving average is 94.79, which suggests AMED is a Sell.
                What is AMED’s Williams % R (14)?
                AMED’s Williams % R (14) is -79.79, which suggests AMED is a Buy.
                  What is AMED’s CCI (14)?
                  AMED’s CCI (14) is -68.82, which suggests AMED is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis